Q2 2025 Artivion Inc Earnings Call Transcript

Aug 7, 2025 / 08:30 PM GMT

Release Date Price: $32.7 (+1.33%)

Transcript 10-Q8-K

Key Points

Positve

Artivion Inc (AORT) reported a strong Q2 2025 with total constant currency revenue growth of over 14% and adjusted EBITDA growth of 33% year over year.
The company successfully launched AMDS in the US following FDA humanitarian device exemption approval, contributing to revenue growth.
Onyx revenue increased 24% year over year, driven by strong market share gains and positive clinical data supporting its use in younger patients.
Artivion Inc (AORT) significantly improved its balance sheet by retiring convertible debt, reducing net leverage.
The company raised its full-year 2025 revenue guidance, reflecting confidence in continued growth and favorable currency impacts.

Negative

The company continues to face challenges from a backlog in tissue processing due to a previous cybersecurity event, although progress is being made to clear it.
Artivion Inc (AORT) incurred $1.7 million in expenses related to the 2024 cybersecurity incident, impacting financial results.
The AMDS launch requires hospitals to complete a multi-step approval process, which could delay widespread adoption.
Despite strong growth, the company faces competitive pressures in the aortic valve market, necessitating continued innovation and differentiation.
The company anticipates a lengthy process for securing FDA approval for its pipeline products, which could delay market entry and revenue realization.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

AORT.N - Artivion Inc
Q2 2025 Artivion Inc Earnings Call
Aug 07, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day, ladies and gentlemen, and welcome to the Artivvian 2nd quarter 2025 earnings call. Our host for today's call is Lane Morgan, Investor Relations, Gil Martin Group. At this time, all participants are in a listen-only mode. Later we will conduct a question and answer session. I would now like to turn the call over to your host Lane. You may begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thanks, operator. Good afternoon and thank you for joining the call today. Joining me today from our Tivian's management team are Pat Macin, CEO and Lance Barry, CFO. Before we begin, I'd like to make

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.